These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32106111)

  • 1. Increased ATP synthesis might counteract hepatic lipid accumulation in acromegaly.
    Fellinger P; Wolf P; Pfleger L; Krumpolec P; Krssak M; Klavins K; Wolfsberger S; Micko A; Carey P; Gürtl B; Vila G; Raber W; Fürnsinn C; Scherer T; Trattnig S; Kautzky-Willer A; Krebs M; Winhofer Y
    JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32106111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence of ectopic lipid accumulation in the pathophysiology of the acromegalic cardiomyopathy.
    Winhofer Y; Wolf P; Krššák M; Wolfsberger S; Tura A; Pacini G; Gessl A; Raber W; Kukurova IJ; Kautzky-Willer A; Knosp E; Trattnig S; Krebs M; Luger A
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4299-306. PubMed ID: 25148232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly.
    Szendroedi J; Zwettler E; Schmid AI; Chmelik M; Pacini G; Kacerovsky G; Smekal G; Nowotny P; Wagner O; Schnack C; Schernthaner G; Klaushofer K; Roden M
    PLoS One; 2008; 3(12):e3958. PubMed ID: 19093000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents.
    Petersen KF; Dufour S; Shulman GI
    PLoS Med; 2005 Sep; 2(9):e233. PubMed ID: 16089501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH.
    Bogazzi F; Raggi F; Ultimieri F; Russo D; Manariti A; D'Alessio A; Viacava P; Fanelli G; Gasperi M; Bartalena L; Martino E
    J Endocrinol; 2007 Sep; 194(3):521-7. PubMed ID: 17761891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body Composition and Ectopic Lipid Changes With Biochemical Control of Acromegaly.
    Bredella MA; Schorr M; Dichtel LE; Gerweck AV; Young BJ; Woodmansee WW; Swearingen B; Miller KK
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4218-4225. PubMed ID: 28945897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative ATP synthesis in human liver measured by localized 31P spectroscopy using the magnetization transfer experiment.
    Schmid AI; Chmelík M; Szendroedi J; Krssák M; Brehm A; Moser E; Roden M
    NMR Biomed; 2008 Jun; 21(5):437-43. PubMed ID: 17910026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype.
    Erickson ML; Haus JM; Malin SK; Flask CA; McCullough AJ; Kirwan JP
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1197-1204. PubMed ID: 31371265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a GH receptor antagonist: a randomized clinical trial.
    Madsen M; Krusenstjerna-Hafstrøm T; Møller L; Christensen B; Vendelbo MH; Pedersen SB; Frystyk J; Jessen N; Hansen TK; Stødkilde-Jørgensen H; Flyvbjerg A; Jørgensen JO
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1227-35. PubMed ID: 22298804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly.
    Lindberg-Larsen R; Møller N; Schmitz O; Nielsen S; Andersen M; Orskov H; Jørgensen JO
    J Clin Endocrinol Metab; 2007 May; 92(5):1724-8. PubMed ID: 17341562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy metabolism and substrate oxidation in acromegaly.
    O'Sullivan AJ; Kelly JJ; Hoffman DM; Baxter RC; Ho KK
    J Clin Endocrinol Metab; 1995 Feb; 80(2):486-91. PubMed ID: 7852509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
    Traussnigg S; Kienbacher C; Gajdošík M; Valkovič L; Halilbasic E; Stift J; Rechling C; Hofer H; Steindl-Munda P; Ferenci P; Wrba F; Trattnig S; Krššák M; Trauner M
    Liver Int; 2017 Oct; 37(10):1544-1553. PubMed ID: 28544208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants in Genes Controlling Oxidative Metabolism Contribute to Lower Hepatic ATP Independent of Liver Fat Content in Type 1 Diabetes.
    Gancheva S; Bierwagen A; Kaul K; Herder C; Nowotny P; Kahl S; Giani G; Klueppelholz B; Knebel B; Begovatz P; Strassburger K; Al-Hasani H; Lundbom J; Szendroedi J; Roden M;
    Diabetes; 2016 Jul; 65(7):1849-57. PubMed ID: 27207512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes.
    Szendroedi J; Schmid AI; Chmelik M; Toth C; Brehm A; Krssak M; Nowotny P; Wolzt M; Waldhausl W; Roden M
    PLoS Med; 2007 May; 4(5):e154. PubMed ID: 17472434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance.
    Abdul-Ghani MA; Muller FL; Liu Y; Chavez AO; Balas B; Zuo P; Chang Z; Tripathy D; Jani R; Molina-Carrion M; Monroy A; Folli F; Van Remmen H; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E678-85. PubMed ID: 18593850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy.
    Møller N; Schmitz O; Jøorgensen JO; Astrup J; Bak JF; Christensen SE; Alberti KG; Weeke J
    J Clin Endocrinol Metab; 1992 May; 74(5):1012-9. PubMed ID: 1569148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid vascularity is increased in patients with active acromegaly.
    Bogazzi F; Manetti L; Bartalena L; Gasperi M; Grasso L; Cecconi E; Rago T; Pinchera A; Martino E
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):65-70. PubMed ID: 12100071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus.
    Wolf P; Fellinger P; Pfleger L; Smajis S; Beiglböck H; Gajdošík M; Anderwald CH; Trattnig S; Luger A; Winhofer Y; Krššák M; Krebs M
    Sci Rep; 2019 Feb; 9(1):2576. PubMed ID: 30796305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.